Evaluation of Adverse Effects of Resorbable Hyaluronic Acid Fillers: Determination of Macrophage Responses

Int J Mol Sci. 2022 Jun 30;23(13):7275. doi: 10.3390/ijms23137275.

Abstract

Resorbable tissue fillers for aesthetic purposes can induce severe complications including product migration, late swelling, and inflammatory reactions. The relation between product characteristics and adverse effects is not well understood. We hypothesized that the degree of cross-linking hyaluronic acid (HA) fillers was associated with the occurrence of adverse effects. Five experimental HA preparations similar to HA fillers were synthesized with an increasing degree of cross-linking. Furthermore, a series of commercial fillers (Perfectha®) was obtained that differ in degradation time based on the size of their particulate HA components. Cytotoxic responses and cytokine production by human THP-1-derived macrophages exposed to extracts of the evaluated resorbable HA fillers were absent to minimal. Gene expression analysis of the HA-exposed macrophages revealed the responses related to cell cycle control and immune reactivity. Our results could not confirm the hypothesis that the level of cross-linking in our experimental HA fillers or the particulate size of commercial HA fillers is related to the induced biological responses. However, the evaluation of cytokine induction and gene expression in macrophages after biomaterial exposure presents promising opportunities for the development of methods to identify cellular processes that may be predictive for biomaterial-induced responses in patients.

Keywords: adverse effects; hyaluronic acid; macrophage responses; resorbable fillers.

MeSH terms

  • Biocompatible Materials / adverse effects
  • Cytokines
  • Dermal Fillers* / pharmacology
  • Humans
  • Hyaluronic Acid* / adverse effects
  • Macrophages

Substances

  • Biocompatible Materials
  • Cytokines
  • Dermal Fillers
  • Hyaluronic Acid